Are supplemental appraisal/reimbursement processes needed for rare disease treatments? An international comparison of country approaches

BACKGROUND: There is increasing recognition that conventional appraisal approaches may be unsuitable for assessing the value rare disease treatments (RDTs). This research examines what supplemental appraisal/reimbursement processes for RDTs are used internationally and how they can be characterised....

Descripción completa

Detalles Bibliográficos
Autores principales: Nicod, Elena, Whittal, Amanda, Drummond, Michael, Facey, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370450/
https://www.ncbi.nlm.nih.gov/pubmed/32690107
http://dx.doi.org/10.1186/s13023-020-01462-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370450/
https://www.ncbi.nlm.nih.gov/pubmed/32690107
http://dx.doi.org/10.1186/s13023-020-01462-0

Ejemplares similares